Amoclafia – 625 LB

Amoclafia – 625 LB Tablets

Composition:

• Amoxicillin (500 mg) – a broad-spectrum penicillin antibiotic.

• Clavulanic Acid (125 mg) – a β-lactamase inhibitor that enhances the activity of Amoxicillin by preventing bacterial resistance.

• Lactic Acid Bacillus (60 million spores) – a probiotic that helps restore gut flora balance, reducing antibiotic-induced diarrhea and gastrointestinal disturbances.

Description:

Amoclafia – 625 LB is a combination antibiotic used to treat a wide range of bacterial infections. The formulation combines Amoxicillin and Clavulanic Acid, which work synergistically to combat both β-lactamase producing and non-producing bacteria. The addition of Lactic Acid Bacillus ensures better gastrointestinal tolerance, minimizing common side effects such as diarrhea and gut flora imbalance.

Indications / Uses:

• Respiratory tract infections (sinusitis, pharyngitis, bronchitis, pneumonia)

• Ear, nose & throat infections (otitis media, tonsillitis)

• Urinary tract infections (UTIs)

• Skin & soft tissue infections (cellulitis, abscesses)

• Dental infections

• Bone & joint infections

Key Benefits:

• Broad-spectrum antibacterial coverage

• Effective against β-lactamase producing organisms

• Probiotic support to maintain healthy gut flora

• Reduces chances of antibiotic-associated diarrhea

Dosage (As Directed by Physician):

• Usually one tablet every 12 hours (depending on infection severity and patient profile).

• Should be taken after meals to reduce gastric irritation.

Safety Information:

• Complete the full course as prescribed to prevent resistance.

• Not recommended in patients with a history of penicillin allergy.

• Dose adjustments may be needed in patients with renal or hepatic impairment.

• Consult a doctor before use in pregnancy or breastfeeding.